Alfred G Gilman - Net Worth and Insider Trading
Alfred G Gilman Net Worth
The estimated net worth of Alfred G Gilman is at least $7 Million dollars as of 2024-11-08. Alfred G Gilman is the Director of Regeneron Pharmaceuticals Inc and owns about 8,912 shares of Regeneron Pharmaceuticals Inc (REGN) stock worth over $7 Million. Details can be seen in Alfred G Gilman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Alfred G Gilman has not made any transactions after 2015-08-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Alfred G Gilman
Alfred G Gilman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Alfred G Gilman owns 2 companies in total, including Regeneron Pharmaceuticals Inc (REGN) , and Eli Lilly and Co (LLY) .
Click here to see the complete history of Alfred G Gilman’s form 4 insider trades.
Insider Ownership Summary of Alfred G Gilman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| REGN | Regeneron Pharmaceuticals Inc | 2015-08-06 | director |
| LLY | Eli Lilly and Co | 2003-11-26 | director |
Alfred G Gilman Latest Holdings Summary
Alfred G Gilman currently owns a total of 1 stock. Alfred G Gilman owns 8,912 shares of Regeneron Pharmaceuticals Inc (REGN) as of August 6, 2015, with a value of $7 Million.
Latest Holdings of Alfred G Gilman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| REGN | Regeneron Pharmaceuticals Inc | 2015-08-06 | 8,912 | 828.42 | 7,382,834 |
Holding Weightings of Alfred G Gilman
Alfred G Gilman Form 4 Trading Tracker
According to the SEC Form 4 filings, Alfred G Gilman has made a total of 0 transactions in Regeneron Pharmaceuticals Inc (REGN) over the past 5 years. The most-recent trade in Regeneron Pharmaceuticals Inc is the sale of 5,000 shares on August 6, 2015, which brought Alfred G Gilman around $3 Million.
Insider Trading History of Alfred G Gilman
- 1
Alfred G Gilman Trading Performance
Alfred G Gilman Ownership Network
Ownership Network List of Alfred G Gilman
Ownership Network Relation of Alfred G Gilman
Alfred G Gilman Owned Company Details
What does Regeneron Pharmaceuticals Inc do?
Who are the key executives at Regeneron Pharmaceuticals Inc?
Alfred G Gilman is the director of Regeneron Pharmaceuticals Inc. Other key executives at Regeneron Pharmaceuticals Inc include SVP Commercial Marion Mccourt , VP & Controller Christopher R. Fenimore , and EVP Research Andrew J Murphy .
Regeneron Pharmaceuticals Inc (REGN) Insider Trades Summary
Over the past 18 months, Alfred G Gilman made no insider transaction in Regeneron Pharmaceuticals Inc (REGN). Other recent insider transactions involving Regeneron Pharmaceuticals Inc (REGN) include a net sale of 10,814 shares made by Marion Mccourt , a net sale of 1,400 shares made by Arthur F Ryan , and a net sale of 7,918 shares made by Bonnie L Bassler .
In summary, during the past 3 months, insiders sold 26,837 shares of Regeneron Pharmaceuticals Inc (REGN) in total and bought 0 shares, with a net sale of 26,837 shares. During the past 18 months, 315,919 shares of Regeneron Pharmaceuticals Inc (REGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 315,919 shares.
Regeneron Pharmaceuticals Inc (REGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Regeneron Pharmaceuticals Inc Insider Transactions
Alfred G Gilman Mailing Address
Above is the net worth, insider trading, and ownership report for Alfred G Gilman. You might contact Alfred G Gilman via mailing address: Dept Of Pharmacology K5 Yuver Of Texas, 5323 Harry Hines Blvd, Dallas Tx 75390.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
